Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy - SET-NET, 16 Jurisdictions, March 29-October 14, 2020
Authors: Kate R. Woodworth, MD1; Emily O’Malley Olsen, PhD1; Varsha Neelam, MPH1; Elizabeth L. Lewis, MPH1; Romeo R. Galang, MD1; Titilope Oduyebo, MD1; Kathryn Aveni, MPH2; Mahsa M. Yazdy, PhD3; Elizabeth Harvey, PhD4; Nicole D. Longcore, MPH5; Jerusha Barton, MPH6; Chris Fussman, MS7; Samantha Siebman, MPH8; Mamie Lush, MA9; Paul H. Patrick, MPH10; Umme-Aiman Halai, MD11; Miguel Valencia-Prado, MD12; Lauren Orkis, DrPH13; Similoluwa Sowunmi, MPH14; Levi Schlosser, MPH15; Salma Khuwaja, MD16; Jennifer S. Read, MD17; Aron J. Hall, DVM1; Dana Meaney-Delman, MD1; Sascha R. Ellington, PhD1; Suzanne M. Gilboa, PhD1; Van T. Tong, MPH1; CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team
Publication Year: 2020
Last Updated: 2021-07-12
Journal: Centers for Disease Control & Prevention
Keywords: Health Disparities
Abstract:
The CDC study, "Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy—SET-NET, 16 Jurisdictions, March 29–October 14, 2020," found that pregnant women with COVID-19 may be at increased risk of having a preterm infant (born before 37 weeks), which may lead to serious health problems for the infant.
File Download:
Source: Link to Original Article
Source: https://www.cdc.gov/mmwr/volumes/69/wr/mm6944e2.htm